TGFB2-antisense-GMCSF vaccine (Gradalis)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameTGFB2-antisense-GMCSF vaccine (Gradalis)
Drug Alias Namegenetically modified autologous cell vaccine (Gradalis)TAG vaccine (Gradalis)
ClassificationVaccines > Application > Therapeutic vaccineCell and gene therapy > Cell therapy
Mechanisms of ActionMacrophage Colony Stimulating Factor 1 agonists
TargetsMacrophage Colony Stimulating Factor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGradalis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGradalis Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A